News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
732,081 Results
Type
Article (43298)
Company Profile (314)
Press Release (688458)
Multimedia
Podcasts (103)
Webinars (19)
Section
Business (210781)
Career Advice (2102)
Deals (36695)
Drug Delivery (111)
Drug Development (83263)
Employer Resources (176)
FDA (16722)
Job Trends (15470)
News (356852)
Policy (34083)
Tag
Academia (2603)
Accelerated approval (15)
Adcomms (25)
Allergies (119)
Alliances (51582)
ALS (136)
Alzheimer's disease (1570)
Antibody-drug conjugate (ADC) (215)
Approvals (16806)
Artificial intelligence (400)
Autoimmune disease (64)
Automation (25)
Bankruptcy (372)
Best Places to Work (11770)
BIOSECURE Act (21)
Biosimilars (151)
Biotechnology (189)
Bladder cancer (125)
Brain cancer (48)
Breast cancer (477)
Cancer (3732)
Cardiovascular disease (307)
Career advice (1773)
Career pathing (34)
CAR-T (222)
CDC (45)
Cell therapy (600)
Cervical cancer (31)
Clinical research (69550)
Collaboration (1300)
Company closure (4)
Compensation (917)
Complete response letters (50)
COVID-19 (2747)
CRISPR (76)
C-suite (557)
Cystic fibrosis (129)
Data (4341)
Decentralized trials (2)
Denatured (32)
Depression (94)
Diabetes (419)
Diagnostics (6613)
Digital health (32)
Diversity (10)
Diversity, equity & inclusion (45)
Drug discovery (181)
Drug pricing (172)
Drug shortages (31)
Duchenne muscular dystrophy (192)
Earnings (90386)
Editorial (47)
Employer branding (21)
Employer resources (153)
Events (118041)
Executive appointments (941)
FDA (19099)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (6)
Frontotemporal dementia (13)
Funding (1163)
Gene editing (162)
Generative AI (30)
Gene therapy (486)
GLP-1 (904)
Government (4736)
Grass and pollen (6)
Guidances (338)
Healthcare (19039)
HIV (42)
Huntington's disease (35)
IgA nephropathy (59)
Immunology and inflammation (210)
Immuno-oncology (16)
Indications (53)
Infectious disease (2958)
Inflammatory bowel disease (173)
Inflation Reduction Act (12)
Influenza (87)
Intellectual property (183)
Interviews (326)
IPO (16885)
IRA (55)
Job creations (4066)
Job search strategy (1498)
Kidney cancer (14)
Labor market (69)
Layoffs (560)
Leadership (26)
Legal (8410)
Liver cancer (85)
Longevity (12)
Lung cancer (535)
Lymphoma (259)
Machine learning (28)
Management (60)
Manufacturing (586)
MASH (131)
Medical device (13681)
Medtech (13702)
Mergers & acquisitions (20666)
Metabolic disorders (1043)
Multiple sclerosis (130)
NASH (17)
Neurodegenerative disease (198)
Neuropsychiatric disorders (50)
Neuroscience (2526)
NextGen: Class of 2025 (6642)
Non-profit (4541)
Now hiring (56)
Obesity (494)
Opinion (262)
Ovarian cancer (130)
Pain (163)
Pancreatic cancer (165)
Parkinson's disease (226)
Partnered (27)
Patents (400)
Patient recruitment (300)
Peanut (55)
People (60184)
Pharmaceutical (91)
Pharmacy benefit managers (25)
Phase I (21556)
Phase II (30587)
Phase III (22924)
Pipeline (2653)
Policy (258)
Postmarket research (2655)
Preclinical (9185)
Press Release (68)
Prostate cancer (188)
Psychedelics (44)
Radiopharmaceuticals (262)
Rare diseases (610)
Real estate (6286)
Recruiting (70)
Regulatory (24286)
Reports (51)
Research institute (2397)
Resumes & cover letters (360)
Rett syndrome (15)
RNA editing (12)
RSV (61)
Schizophrenia (129)
Series A (191)
Series B (147)
Service/supplier (12)
Sickle cell disease (75)
Special edition (22)
Spinal muscular atrophy (152)
Sponsored (35)
Startups (3749)
State (2)
Stomach cancer (15)
Supply chain (93)
Tariffs (91)
The Weekly (69)
Vaccines (918)
Venture capital (62)
Weight loss (330)
Women's health (53)
Worklife (17)
Date
Today (163)
Last 7 days (609)
Last 30 days (2265)
Last 365 days (31055)
2025 (24401)
2024 (35772)
2023 (40630)
2022 (51798)
2021 (56329)
2020 (54791)
2019 (47397)
2018 (35771)
2017 (33136)
2016 (32666)
2015 (38619)
2014 (32516)
2013 (27631)
2012 (29730)
2011 (30487)
2010 (28498)
Location
Africa (790)
Alabama (71)
Alaska (7)
Arizona (272)
Arkansas (14)
Asia (41530)
Australia (6642)
California (9064)
Canada (2803)
China (855)
Colorado (382)
Connecticut (389)
Delaware (256)
Europe (88935)
Florida (1356)
Georgia (295)
Hawaii (2)
Idaho (60)
Illinois (719)
India (46)
Indiana (440)
Iowa (17)
Japan (320)
Kansas (117)
Kentucky (33)
Louisiana (16)
Maine (67)
Maryland (1197)
Massachusetts (6694)
Michigan (280)
Minnesota (528)
Mississippi (4)
Missouri (107)
Montana (29)
Nebraska (25)
Nevada (102)
New Hampshire (69)
New Jersey (2503)
New Mexico (29)
New York (2475)
North Carolina (1258)
North Dakota (8)
Northern California (4167)
Ohio (276)
Oklahoma (21)
Oregon (41)
Pennsylvania (1916)
Puerto Rico (18)
Rhode Island (43)
South America (1166)
South Carolina (48)
South Dakota (1)
Southern California (3491)
Tennessee (145)
Texas (1402)
United States (33095)
Utah (271)
Virginia (230)
Washington D.C. (76)
Washington State (766)
West Virginia (4)
Wisconsin (80)
Wyoming (1)
732,081 Results for "momenta pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Scilex Holding Company Announces the Completion of the First Tranche of the Oramed Pharmaceuticals, Inc. Warrant Repurchase
October 2, 2025
·
7 min read
Press Releases
Reviva Pharmaceuticals Holdings, Inc. Announces Pricing of $9 Million Public Offering
September 19, 2025
·
4 min read
Press Releases
Curanex Pharmaceuticals Inc. Announces Closing of its Initial Public Offering
August 28, 2025
·
4 min read
Press Releases
Curanex Pharmaceuticals Inc. Announces Pricing of its Initial Public Offering
August 27, 2025
·
4 min read
Press Releases
Acurx Pharmaceuticals, Inc. Reports Second Quarter 2025 Results and Provides Business Update
August 12, 2025
·
11 min read
Press Releases
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Re-Files Abbreviated New Drug Application (ANDA) for KETAFREE™, Preservative-Free IV Ketamine
September 30, 2025
·
7 min read
Press Releases
Ocugen, Inc. and Kwangdong Pharmaceutical Co., Ltd. Complete License Agreement of OCU400 Modifier Gene Therapy for Retinitis Pigmentosa in Korea
September 15, 2025
·
5 min read
Press Releases
Lobe Sciences Ltd. and Cynaptec Pharmaceuticals, Inc. to Present a New Therapeutic Approach for the Treatment of Chronic Cluster Headaches at Clusterbusters 2025
September 10, 2025
·
6 min read
Press Releases
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces Expanded Access Policy for NRX-100 (preservative-free ketamine)
August 28, 2025
·
5 min read
Press Releases
UTILITY Therapeutics Announces Acquisition by Alembic Pharmaceuticals Inc.
July 3, 2025
·
7 min read
1 of 73,209
Next
